Content about Morgan Stanley

September 11, 2012
CVS Caremark discusses WAG-Express Scripts impasse, narrower networks during Morgan Stanley event

During Tuesday morning’s Morgan Stanley Healthcare Conference in New York City, CVS Caremark president and CEO Larry Merlo expressed optimism for a strong second half of the year and confidence in retaining a large portion of the prescription volumes gained from the Walgreens-Express Scripts impasse.

NEW YORK — During Tuesday morning’s Morgan Stanley Healthcare Conference in New York City, CVS Caremark president and CEO Larry Merlo expressed optimism for a strong second half of the year and confidence in retaining a large portion of the prescription volumes gained from the Walgreens-Express Scripts impasse.

June 29, 2012
Coty eyes up to $700M in IPO

Coty has filed to raise as much as $700 million in an initial public offering.

NEW YORK — Coty has filed to raise as much as $700 million in an initial public offering. The filing with the Securities and Exchange Commission comes about a month after the beauty company dropped its bid for Avon because of Avon’s “delay and unwillingness to engage in discussions.”

In the filing, Coty told the SEC that it intends to list the Class A common stock on either the NASDAQ or the New York Stock Exchange under the symbol “COTY.” Coty did not reveal how many shares it plans to sell or their expected price.

April 1, 2011
GNC announces IPO

GNC Thursday evening announced its initial public offering of 22.5 million shares of its Class A common stock at an opening price of $16 per share.

PITTSBURGH — GNC Thursday evening announced its initial public offering of 22.5 million shares of its Class A common stock at an opening price of $16 per share.

Of the shares offered, 16 million are being issued and sold by GNC and 6.5 million shares are being sold by selling stockholders.

In addition, selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 3.4 million shares. That offering is expected to close on April 6.

March 25, 2011
P&G, Teva deal: A complementary alignment

In the universe of business partnerships, a joint venture between Teva Pharmaceutical Industries and Procter & Gamble is like two galaxies coming together.

WHAT IT MEANS AND WHY IT'S IMPORTANT — In the universe of business partnerships, a joint venture between Teva Pharmaceutical Industries and Procter & Gamble is like two galaxies coming together.

(THE NEWS: P&G, Teva enter partnership. For the full story, click here.)

February 3, 2011
BJ’s Wholesale placed on sales block

After months of speculation, BJ's Wholesale Club early Thursday morning confirmed the company has decided to explore and evaluate strategic alternatives. Coupled with that announcement was a positive sales story for the year.

WESTBOROUGH, Mass. — After months of speculation, BJ's Wholesale Club early Thursday morning confirmed the company has decided to explore and evaluate strategic alternatives. Coupled with that announcement was a positive sales story for the year.

November 8, 2007
P&G's Freda to head Estee Lauder

Estee Lauder announced on Friday that Procter & Gamble executive Fabrizio Freda will join the...